McMaster University engineers have devised a way to make testing for new drugs more efficient and affordable, and reduce the time for helpful medications to reach the public
Chemical Engineering Associate Professor Todd Hoare and Rabia Mateen, a PhD candidate in Biomedical Engineering, have created a printed paper-based device that can speed up and improve the accuracy of the drug screening process. Their work, which could also be used to diagnose diseases, identify environmental contaminants and pinpoint biological warfare agents, was published in Nature Communications in February.
Currently, drug testing is done in multiple stages, with the first stage involving testing thousands of drug candidates in rapid succession to see how well they bind, block or degrade a molecule of interest to the target disease. Subsequent stages involve more extensive testing of drugs that show promise in this first step.
However, the way this initial first screen is now done results in many inaccurate results, with as many as 95% of drug candidates having no chance of becoming a useful drug. In most cases, these inaccuracies arise from the candidate drugs sticking together during the screen to create particles that physically, instead of chemically, block the activity of the molecule targeted by the drug. Such inaccuracies are only now discovered in the slower and more expensive second stage of screening, resulting in significant time and money wasted during the drug discovery process.
Hoare and Mateen have come up with a way to improve the first stage of testing by using a new printable hydrogel, a network of polymers used in everything from contact lenses to disposable diapers. The thin layers of printed hydrogels can form a cage around the target molecule so drug particles formed can’t access the target molecule and trigger the inaccurate result. Instead, only drugs that chemically bind to the target molecule (the ones that could become practical drugs) are allowed into the hydrogel to give a positive result. The printed device developed is inexpensive and can be used directly in drug screening, improving accuracy without requiring a significant change in how drug screening is now done. As an added benefit, the same sensitivity can be achieved using much less sample volume, further reducing the cost of the screen.
“We had already developed the printing method, but were not sure what to do with the materials,” Mateen said. “Reading about this significant issue in the area of drug screening made me realize that these materials could directly address this problem in a simple and effective way.”
The researchers expect this to make testing more affordable and to speed up the discovery of new drugs. In addition, to help address the surge of antibiotic resistance, the technology can also help to more quickly identify “helper drugs” that can make even drug-resistant bacteria susceptible to our current antibiotics.
“As the next step, we are looking for industry partners to prove the effectiveness of our technology on a full-scale screen of thousands of molecules that can help to extend the lifetime of our current antibiotics,” Hoare said. “We are optimistic this approach can help to bring new effective drugs to patients faster than is currently possible”.
The Latest on: Drug discovery
- EastEnders spoilers: Stuart Highway confesses dark secret to Dot Branning after Rainie Cross makes shock discovery on February 18, 2019 at 11:32 pm
Max Branning’s wife is stunned when she spots the bully at a Narcotics Anonymous meeting Rainie - who fans know is a recovering drug addict – heads off to a Narcotics Anonymous meeting after a drunken ... […]
- Light-based production of drug-discovery molecules on February 18, 2019 at 8:04 am
Photoelectrochemical (PEC) cells are widely studied for the conversion of solar energy into chemical fuels. They use photocathodes and photoanodes to "split" water into hydrogen and oxygen ... […]
- Exclusive insights into the latest innovations at Drug Discovery on February 18, 2019 at 5:24 am
SMi Reports: Gain the latest insights into the drug discovery field at the 3rd annual conference on Drug Discovery Chemistry , next month in London. Last month, personal invitations from our ... […]
- Global Drug Discovery Informatics market detailed in new research report on February 18, 2019 at 2:15 am
Submitted by RNR Market Research. Key players in drug discovery informatics market are IBM (US), Infosys (India), Schrödinger (US), PerkinElmer (US), and Thermo Fisher Scientific (US). These players f... […]
- Exclusive Insights Into the Latest Innovations at Drug Discovery Chemistry on February 16, 2019 at 12:07 am
SMi Reports: Gain the latest insights into the drug discovery field at the 3rd annual conference on Drug Discovery Chemistry, next month in London. London, United Kingdom, February 16, 2019 --(PR.com) ... […]
- Open-science model for drug discovery expands to neurodegenerative diseases on February 15, 2019 at 12:37 pm
Parkinson's disease and Amyotrophic Lateral Sclerosis are the newest frontiers for open science drug discovery, a global movement led by academic scientists in Toronto that puts knowledge sharing ... […]
- Exscientia Hires Director of Data Engineering to Scale up its AI Drug Discovery Platform on February 13, 2019 at 5:14 am
Following a highly successful year and several drug discovery milestones using its flagship AI platform, Exscientia is pleased to welcome Andrew Douglas as the new Director of Data Engineering. […]
- A depression drug that's been called 'the most important discovery in half a century' just got a big step closer to FDA approval (JNJ) on February 12, 2019 at 11:51 am
A drug inspired by ketamine, which has been called "the most important discovery in half a century," is on the cusp of becoming the first new kind of depression medication in 35 years. Called ... […]
- Drug Discovery Informatics Market Expected To Be Worth US$ 6 Billion by 2024 on February 12, 2019 at 6:11 am
Feb 12, 2019 (Heraldkeeper via COMTEX) -- New York, February 12, 2019: The drug discovery is the method in which new applicant medications are discovered. Drug discovery informatics is used in many fi... […]
- How AI Is Revolutionizing Drug Discovery on February 11, 2019 at 10:17 am
mong the business processes most in need of reform, drug discovery likely is near the top of the list. The average cost to bring a new drug to market is $2.6 billion—and the average time it takes is 1... […]
via Google News and Bing News